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Abstract
Objective
To evaluate the association between hypoxaemia and mortality from acute lower respiratory
infections (ALRI) in children in low- and middle-income countries (LMIC).
Design
Systematic review and meta-analysis.
Study Selection
Observational studies reporting on the association between hypoxaemia and death from
ALRI in children below five years in LMIC.
Data Sources
Medline, Embase, Global Health Library, Lilacs, and Web of Science to February 2015.
Risk of Bias Assessment
Quality In Prognosis Studies tool with minor adaptations to assess the risk of bias; funnel
plots and Egger’s test to evaluate publication bias.
Results
Out of 11,627 papers retrieved, 18 studies from 13 countries on 20,224 children met the
inclusion criteria. Twelve (66.6%) studies had either low or moderate risk of bias. Hypoxae-
mia defined as oxygen saturation rate (SpO2) <90% associated with significantly increased
odds of death from ALRI (OR 5.47, 95% CI 3.93 to 7.63) in 12 studies on 13,936 children.
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An Sp02 <92% associated with a similar increased risk of mortality (OR 3.66, 95% CI 1.42
to 9.47) in 3 studies on 673 children. Sensitivity analyses (excluding studies with high risk of
bias and using adjusted OR) and subgroup analyses (by: altitude, definition of ALRI, country
income, HIV prevalence) did not affect results. Only one study was performed on children
living at high altitude.
Conclusions
The results of this review support the routine evaluation of SpO2 for identifying children with
ALRI at increased risk of death. Both a Sp02 value of 92% and 90% equally identify children
at increased risk of mortality. More research is needed on children living at high altitude.
Policy makers in LMIC should aim at improving the regular use of pulse oximetry and the
availability of oxygen in order to decrease mortality from ALRI.
Introduction
Acute lower respiratory infections (ALRI), such as pneumonia and bronchiolitis, are the lead-
ing cause of morbidity and mortality in children under five years of age. According to recent
estimates, every year about 120–156 million cases of ALRI occur globally with approximately
1.4 million resulting in death. More than 95% of these deaths occur in low and middle income
countries (LMIC)[1–3].
Currently there is a significant debate on how to improve the identification of cases of
“severe ALRI“, and on which are the best prognostic factors that can be used in routine care to
identify children with a higher risk of death [4–6].
Pulse oximetry is a non-invasive, simple and reliable method for measuring the saturation
of arterial haemoglobin with oxygen, and it can detect desaturation under a variety of condi-
tions [7–8].
According to a systematic review, hypoxaemia as detected with pulse oximetry has been
observed in 13% of children with WHO-defined pneumonia requiring hospitalisation (severe
and very severe classifications). This corresponds to at least 1.5 to 2.7 million annual cases of
hypoxaemic pneumonia presenting to health-care facilities [9].
Although several research papers have suggested that hypoxia may be associated with
increased odds of death in children with ALRI, no recent systematic review has synthetised the
evidence in this regard. A previous systematic review dates back to year 2001, while a signifi-
cant amount of literature has been published after that date [10]. The aim of this work was to
systematically review and meta-analyse the evidence on the association between hypoxia,
defined using different cut-offs, and ALRI mortality in children in LMIC.
A better understanding of this association may inform both policy makers, health staff
directly involved with clinical management of ALRI in children, and researchers.
Methods
Search strategy and eligibility criteria
In conducting this review we followed the guidelines reported in the PRISMA (Preferred
Reporting Items for systematic reviews and meta-analyses) [11]. and the MOOSE (Meta-analy-
sis of Observational Studies) [12]. A protocol including detailed methods of the review was
developed before starting the review.
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We searched up to January 2015 the following databases: MEDLINE through Pubmed
(from 1956); Embase through OVID (from 1974); Global Health Library (WHO website, no
date restrictions), LILACS through the Virtual Health Library (no date restrictions); Science
Citation Index Expanded (SCI-EXPANDED) through Web of Science (from 1992); Social Sci-
ences Citation Index (SSCI) through Web of Science (from 1992). The search strategy is
reported in Table 1. Manual searches of reference lists were also performed. We did not apply
any language restrictions.
Observational studies were eligible for inclusion if they reported the association between
death from ALRI and hypoxaemia, in children under 5 years of age in LMIC, as defined by the
World Bank [13]. Both studies at hospital level and in the community were included. Studies
reporting selectively on children with very specific co-morbidities, such as studies on children
with cancer, organ transplant, burns, ventilator-acquired pneumonia, SARS or avian flu were
excluded. Studies with less than five events (deaths) were also excluded.
Data collection
Studies were selected for inclusion by two independent authors (ML and MS). Any disagree-
ment was resolved through discussion. The full text of all eligible citations was examined in
detail. Seven authors were contacted for additional information and four provided additional
data, and/or clarifications on the published data.
Two authors (MS and MCP) extracted data from included studies, using a pre-piloted data-
extraction form. Disagreements were resolved by discussion between the two authors and con-
sensus with a third author (ML). We extracted information regarding: country, setting and alti-
tude where the study was performed (altitude, if not specified in the study was attributed based
on the altitude of the location were the study was performed); period of the study; definition of
hypoxaemia; definition for ALRI; characteristics of the population; study design; sample size;
type of analysis performed (univariate or multivariate); confounders.
We extracted both unadjusted and adjusted OR or risk ratios (RR), and crude numbers.
When possible, we converted RR to OR, using a formula for computing OR from RR [14]. To
avoid mistakes due to data manipulation, data were first extracted as in the original paper, and
then converted as needed.
In studies also including children over five years of age, only data on children under five
were extracted. If sorting was not possible, we only included the study if at least 80% of the chil-
dren were under five years old.
Single studies that reported on cut-offs of oxygen saturation rate (SpO2) that could not be
grouped with other studies were grouped as more appropriate to improve the informativeness
of results (Table 2, notes).
Assessment of risk of bias
Two review authors (MS and MCP) independently assessed the risk of bias using the Quality
In Prognosis Studies (QUIPS) [15] tool 15 with minor adaptations (Table A in S1 File). The
tool includes 32 key items divided into 6 domains: 1) Study participation; 2) Study attrition; 3)
Prognostic factor measurement; 4) Outcome measurement; 5) Study Confounding; 6) Statisti-
cal Analysis and reporting. For each study, each individual key item was assessed, and each
domain was graded in one of the following categories of risk of bias, based on whether the
domain fully complied, partly complied, did not comply at all, or did not report in respect of
the characteristic expressed by the items: 1) Low risk of bias; 2) Moderate risk of bias; 3) High
risk of bias; 4) Unknown. The overall risk of bias for each single study was rated as follows
(Table B in S1 File): 1) Low—if all the six domains were scored as low, or if not more than two
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moderate or unknown risks of bias were identified with no high risk of bias; 2) Moderate—if
moderate or unknown risk of bias was identified in three domains without any high risk of
bias, or if a high risk of bias was identified in association with not more than one moderate or
Table 1. Search strategy.
MEDLINE (Pubmed)- vecchia
((("pneumonia"[MeSH Terms] OR pneumonia[Text Word] OR "respiratory infection"[All Fields] OR
"respiratory infections"[All Fields] OR "lower respiratory infection"[All Fields] OR "lower respiratory tract
infections"[All Fields] OR "Bronchiolitis"[Mesh] OR "Bronchiolitis, Viral"[Mesh] OR bronchiolitis [All
Fields]) AND ("child"[MeSH Terms] OR children[Text Word] OR "pediatrics"[MeSH Terms] OR
"paediatrics"[All Fields] OR "paediatric"[All Fields] OR "Infant"[Mesh] OR infant [Text Word] OR newborn
[Text Word] OR newborns [Text Word] OR neonate[Text Word] OR neonates [Text Word] OR infants
[Text Word]) AND ("risk factors"[MeSH Terms] OR "risk factor"[Text Word] OR "risk factors"[All Fields]
OR determinant[All Fields] OR determinant[All Fields] OR determinants[All Fields] OR predictor[All
Fields] OR predictors[All Fields] OR "predictive value"[All Fields] OR "risk"[MeSH Terms] OR "risk"[All
Fields]) AND ("mortality"[Subheading] OR "mortality"[MeSH Terms] OR mortality[Text Word] OR
"death"[MeSH Terms] OR "death"[All Fields] OR fatality[All Fields] OR fatal[All Fields] OR
("death"[MeSH Terms] OR "death"[All Fields] OR "deaths"[All Fields]))) OR ((("pneumonia"[MeSH
Terms] OR pneumonia[Text Word] OR "respiratory infection"[All Fields] OR "respiratory infections"[All
Fields] OR "lower respiratory infection"[All Fields] OR "lower respiratory tract infections"[All Fields] OR
"Bronchiolitis"[Mesh] OR "Bronchiolitis, Viral"[Mesh] OR bronchiolitis [All Fields]) AND ("child"[MeSH
Terms] OR children[Text Word] OR "pediatrics"[MeSH Terms] OR "paediatrics"[All Fields] OR
"paediatric"[All Fields] OR "Infant"[Mesh] OR infant [Text Word] OR newborn[Text Word] OR newborns
[Text Word] OR neonate[Text Word] OR neonates [Text Word] OR infants [Text Word]) AND (hypoxemia
OR hypoxaemia OR hypoxia OR “oxygen saturation”) AND ("mortality"[Subheading] OR
"mortality"[MeSH Terms] OR mortality[Text Word] OR "death"[MeSH Terms] OR "death"[All Fields] OR
fatality[All Fields] OR fatal[All Fields] OR ("death"[MeSH Terms] OR "death"[All Fields] OR "deaths"[All
Fields])))
GLOBAL HEALTH LIBRARY (WHO web site)
((pneumonia OR "respiratory infection" OR "respiratory infections" OR Neumoni$ OR Infeccao
Respiratoria OR Infeccion Respiratoria OR Infeccoes Respiratorias OR Infecciones Respiratorias) AND
(child$ OR infant$ OR pediatric$ OR paediatric$ OR Nino$ OR Crianca$ OR infant$ OR Pediatric$ OR
newborn$ OR neonat$ OR "recien nacido" OR "recem nacido") AND (hypoxemia OR hypoxaemia OR
hypoxia OR “oxygen saturation” OR"risk factors" OR "risk factor" OR determinant$ OR predict$ OR risk
$) AND (mortality OR death$ OR fatal$ OR letal$ OR outcome$ OR mortalidad OR mortalidade OR
muerte OR Morte OR desenlace$ OR obito$))
LILACS (Virtual Health Library)
(pneumonia OR "respiratory infection" OR "respiratory infections" OR Neumoní$ OR Infecção
Respiratoria OR Infección Respiratoria OR Infecçoes Respiratorias OR Infecciones Respiratorias OR
bronchiolitis) (child$ OR infant$ OR pediatric$ OR paediatric$ OR Niño OR ninos OR Criança OR
Crianças OR infantil OR infantiles OR Pediátrico OR Pediátricos) (mortality OR death$ OR fatal$ OR
letal$ OR outcome$ OR mortalidad OR mortalidade OR muerte OR Morte OR desenlace$)
SCI-EXPANDED and SSCI (Web of Science)
((pneumonia OR “respiratory infection” OR “respiratory infections” OR "lower respiratory tract infections"
OR "bronchiolitis") AND (child* OR pediatric* OR paediatric* OR infant* OR newborn* or neonat*)
AND (“risk factors” OR “risk factor” OR predictor* OR risk* OR determinant* OR "predictive value")
AND (mortality OR death* OR fatal*)) OR ((pneumonia OR “respiratory infection” OR “respiratory
infections” OR "lower respiratory tract infections" OR "bronchiolitis") AND (child* OR pediatric* OR
paediatric* OR infant* OR newborn* or neonat*) AND (“hypoxemia” OR hypoxaemia OR hypoxia OR
“oxygen saturation”) AND (mortality OR death* OR fatal*))
EMBASE
1)pneumonia/co, dm, dt, ep, et, pc, th [Complication, Disease Management, Drug Therapy,
Epidemiology, Etiology, Prevention, Therapy];2) (children or infant*OR childhood or preschool*).mp.
[mp = title, abstract, subject headings, heading word, drug trade name, original title, device
manufacturer, drug manufacturer, device trade name, keyword]; 3) limit 2 to human; 4) 1 and 3; 5)
developing countries.mp. or developing country/; 6) (Asia* or Africa* or South America).mp. [mp = title,
abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug
manufacturer, device trade name, keyword]; 7) LMIC.mp.; 8) "low and middle income countries".mp.; 9)
5 or 6 or 7 or 8; 10) 4 and 9.
doi:10.1371/journal.pone.0136166.t001
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Table 2. Characteristics of included studies.
Author and
year of
publication
Type
of
study
Country Period
of
study
Setting
(source
population)
Altitude
(meters
above
sea
level)
Cut off
of Sp02
used
Diagnostic
criteria for
ALRI
Age
group
(months)
Other
characteristics
of the study
population
ALRI
mortality
+
N° of
children
evaluated
for
hypoxemia
Chisti 2011 CO BANGLADESH 2007 Hospital
(Urban)
4 90% Clinical WHO 0–59 All severe ALRI;
All ALRI and
diarrhoea
12.1 198
Chisti 2013 CC BANGLADESH 2011–
2012
PICU
(Urban)
4 90% Radiological 0–59 All severe ALRI;
All severe acute
malnutrition
─ 140
Demers
2000
CO CENTRAL
AFRICAN
REPUBLIC
1996–
1997
Hospital
(Urban)
386 Various* Clinical WHO 0–59 - 12.5 392
Djelantik
2003
CO INDONESIA 1999–
2001
Three
Hospitals
(Rural)
26 85% Clinical WHO 0–23 All severe ALRI 11.6 4306
Duke 2001 CO PNG 1998–
1999
Hospital
(Rural)
1600 Various* Clinical WHO
combined with
PNG guidelines
1–59 All severe ALRI;
All with
Sp02<85%
6.5 703
Graham
2011
CO MALAWI 2005–
2006
Hospital
(Urban)
1039 90% Clinical WHO 2–156
(12%>60)
All severe ALRI;
HIV infected
>50%
10.1 327
Junge 2006 CO GAMBIA 1993–
1994
Hospital
(Urban)
29 Various* Clinical 41%<12 - 4.6 436
Mc Nally
2007
CO SOUTH
AFRICA
2001–
2002
Hospital
(Urban)
22 92% Clinical WHO 1–59 All severe ALRI;
>50% HIV
infected
15.1 358
Mwaniki
2009
CO KENYA 2002–
2005
Hospital
(Rural)
Sea level 90% Clinical WHO 0–59 - 7.8 5489
Nantanda
2008
CO UGANDA 2005–
2006
Hospital
(Urban)
1260 92% Clinical WHO 2–59 All severe ALRI 15.3 157
Nantanda
2014
CO UGANDA 2011–
2012
Hospital
(Urban and
Rural)
1260 92% Clinical WHO ° 2–59 Severe ALRI 3.6 614
Onyango
1993
CO KENYA 1989 Hospital
(Urban)
1670 90% Clinical 0–36 - 10.0 209
Reed 2012 CO SOUTH
AFRICA
1998–
2001
Hospital
(Urban)
1753 90% Clinical <24 - 7.2% 4148
Rodríguez
2010
CC COLOMBIA 2007–
2008
Four
Hospitals
(Ward
+PICU)
(Urban)
2640 90% ICD-10 death
certiﬁcate for
ALRI and
clinical records
<60 - ─ 226
Sigauque
2009
CO MOZAMBIQUE 2004–
2006
Hospital
(Rural)
50 90% Clinical WHO 0–23 All severe ALRI 6.5 584
Smyth 1998 CO ZAMBIA 1994–
1995
Hospital
(Rural)
1150 90% Clinical WHO 1–59 All severe ALRI 14.6 158
Usen 1999 CO GAMBIA 1993–
1995
Two
Hospitals
(Urban)
2 90% Clinical 2–33 - 3.4 1072
Zhang 2013 CO CHINA 2007–
2010
PICU
(Urban)
4 92% Clinical WHO 0–60 All severe ALRI 5.8 707
* Demers used the following cut-offs: > = 95; 90–94.9; 85–89.9; <85. We grouped results as follows: > = 90; <90.
Duke used the following cut-offs: 70–84; 50–69; <50. We grouped results as follows: 70–84 vs < 70.
Junge used the following cut-offs: >94; 90–94; <90. We grouped results as follows: > = 90 vs <90.
° After admittance, children were further diagnosed using further South African Guideline for bronchiolitis, and GINA guidelines for asthma
doi:10.1371/journal.pone.0136166.t002
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unknown risk of bias; 3) High—if a high risk of bias was identified in two or more domains
independently from the grading in the other domains, or if moderate or unknown risk of bias
was identified in four or more domains independently from grading in the other domains.
Statistical analyses
When meta-analysis was possible and appropriate we generated a pooled OR using the
inverse-variance weighting method. As we expected high heterogeneity among studies (in the
population, in the definition of ALRI, in the definition of hypoxaemia, and the overall method-
ology), we selected a priori the DerSimonian and Laird random effect model [16], which
accounts for intra- and inter- study variability.
Pooled data were presented in a forest plot, where studies are ordered chronologically; data
from one study that could not be meta-analyzed were described in text.
We tested the null hypothesis that all studies evaluate the same true effect by the Cochran’s
Q test, with p<0.05 considered statistically significant. The degree of heterogeneity between
studies was assessed by visual inspection of the forest plots and I-squared (I2) statistic with its
95% confidence intervals. Heterogeneity was considered low for I2 values between 25%-50%,
moderate for 50%-75%, and high for75% [17].
Sensitivity analyses and exploration of heterogeneity
We performed sensitivity analyses to examine the effect of removing the studies with high risk
of bias and of using adjusted OR rather than the crude OR, when the former was available.
Using subgroup and metaregression analysis, we planned to explore the effect of the follow-
ing study-level factors: a) Altitude (studies in populations living at 0–1,499 meters above sea
level vs 1,500–2,499 meters vs> 2,500 meters); b) different definitions of ALRI used (WHO
definition versus other definitions); c) income (low income countries versus lower middle
income countries, as defined by the World Bank13 at the moment of the study start—no study
was available for the category of upper middle income countries); d) HIV country prevalence
(high HIV prevalence versus non-high HIV prevalence, where a high HIV prevalence was
defined as a prevalence of HIV in the population of 15–49 year-olds at the time of the
study> 5%.
We assessed potential publication bias and small study effects with funnel plots and the
Egger test [18].
All statistical analysis was performed using Stata version 12 [19].
Results
Characteristics of the studies
The systematic search yielded overall 11,627 records (Fig 1). Overall 18 studies [20–37] from
13 countries on 20,224 children met the inclusion criteria. Characteristics of the studies are
summarized in Table 2.
All except three studies were published during the last 15 years. Twelve studies were per-
formed in Africa (two studies in Gambia, Kenya, Uganda and South Africa; one each in Central
African Republic, Malawi, Mozambique, Zambia), three in South East Asia (two in Bangladesh,
one in Indonesia), two in Western Pacific Region (one in Papua New Guinea, one in China)
and one in South America (Colombia). All studies were hospital-based, 12 were conducted in
an urban setting setting, five in a rural setting, and one in both. Three studies were multi-cen-
tered. Fourteen studies were performed at an altitude of between 0–1,499 meters above sea
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level, three studies at an altitude between 1,500–2,499 meters, and one study at an altitude
of> 2,500 meters above sea level (this study used as a cut-off of Sp02 a value of 90%).
Twelve studies contrubuted on the evaluation of hypoxaemia defined as a cut-off oxygen of
SpO2 of 90%, four studies on a cut-off of 92%; one study on a cut-off of 85%, and one study on
cut-offs of 70% versus 70–84%.
Overall, 12 studies used the WHO definition of pneumonia, while the other used other clini-
cal criteria (five studies), radiological classification (one study) and ICD10 classification (one
study). Eleven studies also included newborns. Eleven studies enrolled children with either
severe or very severe pneumonia. Two studies in Bangladesh enrolled children who all pre-
sented either diarrhea (one study) or malnutrition (the other study) as a co-morbidity. In two
studies in Malawi and South Africa respectively over half of enrolled children were HIV
infected. Mortality rate in the included studies ranged from 3.4% to 15.3%.
Fig 1. PRISMA 2009 Flow Diagram.
doi:10.1371/journal.pone.0136166.g001
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One study [32] reported data separatly on HIV-positive and HIV-negative children, and
was included in the meta-analysis as two sub-studies.
Risk of bias for included studies is reported in Fig 2. Six studies were considered at high risk
of bias, with lack of adjustment for confounding and other aspects of the statistical analysis
being the most frequent risk of bias. The other 12 studies were considered either at low (eight
studies) or at moderate (four studies) risk of bias.
Results of the meta-analysis
Results of the meta-analysis are reported in Fig 3. Seventeen studies were included in the meta-
analysis.
Hypoxaemia defined with a cut-off for oxygen saturation rate (SpO2) below 90% was associ-
ated with significant increased odds of death from ALRI (OR 5.47, 95% CI 3.93 to 7.63) in 13
studies on 13,928 children.
An Sp02 below 92% compared to over 92% was associated with an increased risk of mortal-
ity of 3.66 (95% CI 1.42 to 9.47) in 3 studies on 673 children. Using the same cut-off of 92%,
one study on 614 children found an HR of 12.2 (1.6–92.0) [29].
One study on 4,306 Indonesian children using a cut-off of SpO2 of 85% identified an OR of
5.61(95% CI 4.48 to 7.03).
A study in Papua New Guinea on 6,703 children comparing an SpO2 of< 70% to values
70–84% resulted in an OR of 2.46 (95% CI 1.30 to 4.65).
Heterogeneity of results was moderate in both the group of studies using a SpO2 cut-off
value of 92% (3 studies, I2 = 61.4%), and in the group of studies using a cut-off value of 90%
(13 studies, 65.3%).
Fig 2. Risk of bias in the included studies. Red = High risk of bias. Yellow = Moderate risk of bias. Green = Low risk of bias. White = Unknown risk of bias.
doi:10.1371/journal.pone.0136166.g002
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Sensitivity analyses
Results of sensitivity analyses are reported in Table 3. When only studies with either low or
moderate risk of bias were included in the analysis (11 studies), hypoxaemia was overall still
significantly associated with increased odds of mortalty (OR 5.71, 95% CI 4.34 to 7.50).
Both when all studies were retained in the meta-analysis, but adjusted OR were used for
studies providing them, and when only studies prividing an adjusted ORs were analysed (four
studies), hypoxaemia was still significantly associated with increased odds of mortalty
(OR = 4.66, 95% CI 3.50 to 6.19; OR = 4.69, 95% CI 2.55 to 8.61).
Subgroup analyses and metaregression
Results of the subgroup analysis and metaregression are reported in Table 4.Overall, subgroup
analysis did not affect results. When studies were sub-grouped based on different altitudes
Fig 3. Association between hypoxemia and death.Notes: seventeen studies were able to be pooled in the meta-analysis. The remaining study that could
not be meta-analysed used an SpO2 cut-off of 92% and found an HR of 12.2 (95%CI 1.6–92.0).29.
doi:10.1371/journal.pone.0136166.g003
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where the studies were performed, the overall association between hypoxaemia and mortality
persisted both in the subgroup studies in populations living at 0–1,499 meters above sea level
(OR 5.23, 95%CI 3.99 to 6.86, 13 studies) and at 1,500–2,499 meters above sea level (OR 5.34,
95%CI 2.74 to 10.60, 3 studies, 4 comparisons). Fig 4 and Fig 5 report the subgroup analysis in
detail: overall in both subgroups all explored SpO2 cut-offs were significantly associated with
increased odds of mortality, without significant differences between different cut-offs, although
in the subgroup of studies at 0–1,499 meters (Fig 5) there was a trend for higher risk of mortal-
ity with decreasing Sp02 cut-offs (92%: OR 3.66, 95% CI 1.42 to 9.47; 90%: OR 5.80, 95% CI
3.98 to 8.46). One only small study (255 children) reporting on a population in Colombia living
at an altitude> 2,500 meters, and evaluating an Sp02 of 90%, did not identify a significant
association with increased mortalty risk (OR 1.51, 95%CI 0.75 to 3.04).
When studies where subgrouped based on different diagnostic criteria for ALRI (WHO cri-
teria vs other criteria), hypoxaemia was significanty associated with mortality in both sub-
groups (OR 5.06, 95% CI 3.79 to 6.76; OR 4.84, 95% CI 2.82 to 8.30, p = 0.811).
When studies where subgrouped based on incomes in the country (low vs lower-middle
medium) hypoxaemia was significanty associated with mortality in both subgroups (OR 4.92,
95% CI 3.78 to 6.40; OR 5.19, 95% CI 2.64 to 10.21, p = 0.982)
When studies where subgrouped based on HIV prevalence in the country, hypoxaemia was
significanty associated with mortality in both subgroups (OR 4.43, 95% CI 2.57 to 7.64; OR
4.33, 95% CI 3.02 to 6.02, p = 0.971).
Table 3. Sensitivity analyses.
Sensitivity analysis including only studies with low or moderate risk of bias
N°. of studies with low
or moderate risk of bias
N°. of studies included in
the sensitivity analysis
Pooled OR (95%CI) when including in the
meta-analysis only studies with low or
moderate risk of bias
12 11 (12 comparisons) 5.71 (4.34–7.50)
Sensitivity analysis including only studies providing an adjusted OR
N° of studies with
adjusted OR available
N°. of studies included in
the sensitivity analysis
Pooled OR (95%CI) of the 5 studies with
adjusted OR
4 4 (5 comparisons) 4.69 (2.55–8.61)
Sensitivity analysis on all studies after substituting crude OR with adjusted OR for studies were
adjusted OR was available
N° of studies with
adjusted OR available
N°. of studies included in
the sensitivity analysis
Pooled OR (95%CI) after substituting crude
OR with adjusted OR
4 17 (18 comparisons) 4.66 (3.50–6.19)
doi:10.1371/journal.pone.0136166.t003
Table 4. Subgroup analysis andmetaregression.
Variable Comparisons N° of studies Pooled OR I2 (%) p from meta-regression
Altitude 0–1499 13 5.23 (3.99–6.86) 52.1
1500–2499 3 5.39 (2.74–10.60) 71.2
>2500 1 1.51 (0.75–3.04) ─
Diagnosis WHO 10 5.06 (3.79–6.76) 54.6
Other diagnosis 7 4.84 (2.82–8.30) 73.8 0.811
Income Low income countries 12 4.92 (3.78–6.40) 47.7
Lower-medium income countries 5 5.19 (2.64–10.21) 80.7 0.982
HIV prevalence Low HIV prevalence 7 4.43 (2.57–7.64) 74.4
High HIV prevalence 9 4.33 (3.02–6.02) 47.8 0.971
doi:10.1371/journal.pone.0136166.t004
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Publication bias
The funnel plot is reported as Fig 6. Egger tests resulted in a p value of 0.971 (not suggestive of
publication bias).
Discussion
Interpretation of the results
This systematic review synthesises the available evidence on the association between hypoxae-
mia and ALRI mortality in children in LMIC. Results from this review confirm the importance
of measuring oxygen saturation in children with ALRI in order to identify children with higher
risk of mortality. Overall, the association with hypoxaemia is well documented: the pooled
analysis of 12 studies showed that children with SpO2 below 90% have a 5.4 fold increase in the
Fig 4. Subgroup analysis in the population living at 0–1,499 meters above sea level.
doi:10.1371/journal.pone.0136166.g004
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risk of death, while 3 studies showed that children with SpO2 below 92% have a 3.6 fold
increase in odds of death. Sensitivity analyses (including only studies with either low or moder-
ate risk of bias and using adjusted OR) and subgroup analyses (by altitude, definition of ALRI,
country income, HIV prevalence) did not change the results. Tests for publication bias did not
suggest their existence.
A previous review published several years ago [10] identified only three studies reporting on
hypoxaemia and mortality in children with ALRI. This review updates the current evidence-
synthesis on this subject.
Strengths and limitations
In performing this review we used a comprehensive search strategy without language restric-
tions; quality of retrieved studies was overall fair, without suggestion of publications bias. We
were aware of the possibility of introducing bias at every stage of the review process and tried
to minimise this aspect by following strict methods and standards suggested for systematic
reviews [11,12,15].
Moderate heterogeneity of results among studies may be explained by heterogeneity in the
characteristics of the studies, such as design, setting, type of population included, definition of
Fig 5. Subgroup analysis in the studies with a population living at 1,500–2,500 meters above sea level.
doi:10.1371/journal.pone.0136166.g005
Hypoxaemia as a Mortality Risk Factor in ALRI in Children
PLOS ONE | DOI:10.1371/journal.pone.0136166 September 15, 2015 12 / 17
ALRI, and power of the study (which may explain large confidence intervals in some
instances). Subgroup analyses reduced part of the heterogeneity in some sub-groups, however
heterogeneity may be also explained by other confounding factors affecting mortality rates,
such as the different quality of care provided in the studies, and different algorithms used to
treat hypoxaemia.
This review identifies a lack of data on the prognostic value of Sp02 in populations living at
very high altitudes (> 2,500 meters above sea level).
Other limitations in this review are related to limitations in the designs of the included stud-
ies and in the availability of individual patient data: few studies in the analysis provided had
adjusted OR after correction for other related risk factors, and no individual patient database
was availble to generate pooled-adjusted OR. However, sensitivity analysis using adjusted ORs
confirmed the primary results.
Implication for policies and research
The results of this review support the routine evaluation of oxygen saturation rate for identify-
ing children with ALRI at higher risk of death. This is in line with current WHO guidelines,
which recommend determining the presence of hypoxaemia with pulse-oximetry in all
Fig 6. Funnel plot to explore publication bias.
doi:10.1371/journal.pone.0136166.g006
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children with ALRI [38–39]. This indication recognises the inaccuracy and unreliability of clin-
ical signs to detect cases who need oxygen, together with the role of oxygen as an essential treat-
ment for pneumonia [39]. Two systematic reviews highlighted that neither single nor
combined symptoms and signs are sufficiently effective for predicting hypoxaemia among
young children with ALRI [39–41].
Currently, there are different types of indications regarding at which Sp02 value to start oxy-
gen therapy [38–47]. WHO recommends starting oxygen therapy when the saturation rate is
below 90%, when at an altitude< 2,500 meters above sea level [38–39]. Other guidelines on
acute respiratory conditions indicate as a threshold to start oxygen therapy either a value of
SpO2< 90% [42–44] or< 92% [45–46], or between 90–92% [47]. Direct evidence in support
of any specific Sp02 threshold for starting supplementation with oxygen is lacking: a systematic
review could not identify any study comparing outcomes of children receiving oxygen at differ-
ent cut-offs of hypoxaemia [48]. Results of our review indicate that both the category of chil-
dren with an SpO2< 90% (OR 5.47, 95% CI 3.93 to 7.63) and children with SpO2< 92%
(3.66, 95% CI 1.42 to 9.47) have an increased risk of mortality, without significant difference in
the ORs between the two Sp02 thresholds, and with similar sesults both at low altituides and at
moderate altitudes (<2,500 meters above sea level). This suggests that even children with SpO2
below 92% may benefit from oxygen therapy.
For children living at high altitude (> 2,500 meters above sea level), WHO recommends a
lower cut-off for given oxygen, such as SpO2< 87% [38–39]. This review identifies only a
small study (255 children) reporting on a population in Colombia living at an altitude> 2,500
meters, and evaluating an Sp02 of 90%, without any significant association with increased
mortalty risk (OR 1.51, 95%CI 0.75 to 3.04). This may suggest that the use of Sp02 thresholds
lower than 90% is appropriate, although there is no evidence in support of any precise cut-off.
Further studies are therefore needed to explore the prognistic value of different cut-offs of oxy-
gen saturation for populations living at very high altitudes (> 2,500 meters above sea level).
Effective and cheap systems for delivering oxygen have been developed and tested in low-
resource countries [49–51].Policy makers should aim at improving the availability of such oxy-
gen delivery systems together with the availability of pulse oximetry in LMIC. Alongside the
provision of equipment, training and monitoring to promote effective use of available resouces
is also needed. New relatively simple technologies, utilising for example smartphone devices
such as pulse oxymeter, may facilitate the implementation of such practices [52].
This review adds some information to the current knowledge of prognostic factors for ALRI
mortality in children in LMIC. A recent systematic review [53] highlighted that a broad range
of factors are associated with increased odds of death for ALRI in children, including both
child-factors (age, female sex, prematurity, low birth weight, malnutrition, inadequate breast-
feeding, infections with HIV/AIDS and other co-morbidities, chronic diseases), parental fac-
tors (socio-economical status, maternal education), envoromental factors (indoor air pollution,
second hand smoke exposure). The current knowledge should now be integrated in order to
develop and field test comprehensive prognostic indexes–such as scoring systems including
both hypoxaemia and other child, parental and environmental risk factors- in order to identify
children at higher risk of ALRI mortality who should be targeted by more intensive interven-
tions and follow up care.
Conclusions
The results of this review support the routine evaluation of oxygen saturation rate for identify-
ing children with ALRI at higher risk of death. Despite the lack of direct evidence in support of
any specific Sp02 threshold for starting supplementation with oxygen, this review shows that
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both an Sp02 value of 92% and 90% equally identify children at increased risk of mortality. Fur-
ther studies should focus on children living at high altitudes. Policy makers should aim at
improving the availability of pulse oximetry and oxygen in LMIC.
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